RecallRadar

FDA Drug recall D-0812-2021

Metoprolol Tartrate Tablets USP 100 mg, 1000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA Inc. 279 Princeton-Highstown Road…

On 2021-09-29 the FDA classified a Class II recall of Metoprolol Tartrate Tablets USP 100 mg, 1000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA Inc. 279 Princeton-Highstown Road… by Aurobindo Pharma Usa, citing presence of Foreign Substance: Product complaints received for the presence of metal wire in one tablet.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0812-2021
ClassificationClass II
Statusterminated
Initiated2021-09-09
Published2021-09-29
Last updated2026-09-13 11:52 UTC
CompanyAurobindo Pharma Usa
DistributionUS

Product

Metoprolol Tartrate Tablets USP 100 mg, 1000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA Inc. 279 Princeton-Highstown Road East Windsor, NJ 08520, NDC 65862-064-99

Reason

Presence of Foreign Substance: Product complaints received for the presence of metal wire in one tablet.

Identifiers

ndc65862-062-01
ndc65862-062-99
ndc65862-063-60
ndc65862-063-01
ndc65862-063-99
ndc65862-064-60
ndc65862-064-01
ndc65862-064-99
code_infoLot: MJ1019025-A, Exp. date 04/2022

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0812-2021%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.